
Doxryth CV 50mg/31.25mg Syrup
Marketer
Penryth Labs Private Limited
Salt Composition
Cefpodoxime Proxetil (50mg) + Clavulanic Acid (31.25mg)
Overview Doxryth CV 50mg/31.25mg Syrup
Doxryth CV 50mg/31.25mg Syrup combines two powerful antibiotics to effectively combat serious bacterial infections in children. This medication treats infections affecting various areas, including the ears, throat, lungs, skin, and urinary tract. Its mechanism involves halting bacterial multiplication, thereby controlling infection spread. Administer the syrup to your child one hour before or two hours after meals; however, if stomach upset occurs, give it with food. Strictly adhere to the prescribed dosage, which is tailored to your child's infection type, severity, age, and weight. If your child vomits the medication within 30 minutes, repeat the dose; however, avoid doubling the dose if it's nearing the next scheduled administration. Mild, temporary side effects like vomiting, diarrhea, nausea, rash, and headache may occur, usually resolving as your child adjusts. Persistent or troubling side effects warrant immediate medical attention. Always provide your child's doctor with a complete medical history, including allergies, heart conditions, blood disorders, birth defects, respiratory issues, lung problems, digestive problems, skin conditions, liver problems, and kidney issues. This information is essential for appropriate dosage and treatment planning.
Primary Ingredients of Doxryth CV 50mg/31.25mg Syrup
There is no text provided to rephrase.
Uses of Doxryth CV 50mg/31.25mg Syrup
Managing infections of the airways
Major Benefits of Doxryth CV 50mg/31.25mg Syrup:
Administer this medication precisely as your physician prescribes, adhering to both dosage and treatment length. Consult the product label for detailed instructions prior to consumption. Use a measuring device to accurately dispense the oral dose. Ensure thorough shaking before each use. Doxryth CV 50mg/31.25mg Syrup can be ingested with or without food; however, consistent timing is recommended for optimal results.
Common Side effects of Doxryth CV 50mg/31.25mg Syrup:
- Nausea
- Diarrhea
- Headache
- Rash
- Abdominal pain
- Vaginal infection
- Fungal infection of vagina
How to use Doxryth CV 50mg/31.25mg Syrup:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Always consult the product label for complete instructions prior to ingestion. Use a measuring device for accurate dosing and consume orally. Ensure thorough shaking before each use. Doxryth CV 50mg/31.25mg Syrup can be ingested with or without food; however, consistent timing is recommended for optimal results.
How Doxryth CV 50mg/31.25mg Syrup works:
Doxryth CV Syrup, containing 50mg Cefpodoxime Proxetil and 31.25mg Clavulanic Acid, employs a dual-action approach to combat bacterial infections. Cefpodoxime Proxetil, an antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Clavulanic Acid, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thereby boosting Cefpodoxime Proxetil's effectiveness.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Doxryth CV 50mg/31.25mg Syrup may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Doxryth CV 50mg/31.25mg Syrup during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Doxryth CV 50mg/31.25mg syrup poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, suggesting no infant harm.
DrivingUNSAFE
Taking Doxryth CV 50mg/31.25mg Syrup might lead to adverse reactions, including allergic responses, dizziness, or seizures, potentially impairing your driving ability.
KidneySAFE IF PRESCRIBED
The use of Doxryth CV 50mg/31.25mg Syrup is considered safe for individuals with kidney impairment; dosage alteration is generally unnecessary. Nevertheless, children suffering from severe kidney disease may need adjusted dosages. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Doxryth CV 50mg/31.25mg Syrup can be administered to patients with liver disease without dose modification. However, for children with severe liver impairment, parental consultation with a physician is advised prior to administration.
What if you forget to take Doxryth CV 50mg/31.25mg Syrup :
Remain calm. Unless otherwise directed by your child's physician, administer the missed dose immediately upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Continue following the prescribed medication schedule; avoid doubling the dose to compensate for a missed one.
Facts to Know About Doxryth CV 50mg/31.25mg Syrup
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
